 |
We at Sunzen Group believe that R&D is the most
crucial activity for the Group, as it forms the foundation of Sunzen's
continuous innovation. The Group typically allocates 1% to 3% of annual
revenue for R&D initiatives.
Our R&D efforts are guided by the following policies:
| a) |
To introduce and develop innovative "green"
animal health products that are progressive and have a large untapped
market potential. These products are based on natural substances that
are safe for humans, animals and the environment.
|
| b) |
To maximize the value of our existing products by
enhancing the features, efficacy, species applicability and/or
discovering new uses for it.
|
| c) |
To conduct our research activities in an ethical
manner in accordance with standard scientific methods and practices.
|
| d) |
To continuously invest in human capital and
R&D assets as they are the foundation of our long-term business
success.
|
|
